559 related articles for article (PubMed ID: 27855494)
1. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
Pandit J; Sultana Y; Aqil M
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
3. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
4. Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration.
Pandit J; Sultana Y; Aqil M
Carbohydr Polym; 2021 Sep; 267():118217. PubMed ID: 34119171
[TBL] [Abstract][Full Text] [Related]
5. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
6. Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies.
Khan N; Ameeduzzafar ; Khanna K; Bhatnagar A; Ahmad FJ; Ali A
Int J Biol Macromol; 2018 Sep; 116():648-663. PubMed ID: 29723623
[TBL] [Abstract][Full Text] [Related]
7. Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design,
Ameeduzzafar ; Khan N; Alruwaili NK; Bukhari SNA; Alsuwayt B; Afzal M; Akhter S; Yasir M; Elmowafy M; Shalaby K; Ali A
Iran J Pharm Res; 2020; 19(1):292-311. PubMed ID: 32922488
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.
Hayee R; Iqtedar M; Albekairi NA; Alshammari A; Makhdoom MA; Islam M; Ahmed N; Rasool MF; Li C; Saeed H
J Infect Public Health; 2024 May; 17(5):906-917. PubMed ID: 38569270
[TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
Yang Y; Xie XY; Mei XG
Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
[TBL] [Abstract][Full Text] [Related]
10. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
Salama AH; Mahmoud AA; Kamel R
AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
Zhao K; Zhang Y; Zhang X; Shi C; Wang X; Wang X; Jin Z; Cui S
Int J Nanomedicine; 2014; 9():4609-19. PubMed ID: 25356070
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
15. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
[TBL] [Abstract][Full Text] [Related]
16. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
Grabovac V; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
[TBL] [Abstract][Full Text] [Related]
18. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
19. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
Int J Biol Macromol; 2014 Apr; 65():479-91. PubMed ID: 24530326
[TBL] [Abstract][Full Text] [Related]
20. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]